Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
21.96
+0.29 (1.34%)
Mar 7, 2025, 4:00 PM EST - Market closed
Catalyst Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 7, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,667 | 2,489 | 1,792 | 1,936 | 698 | 346 | Upgrade
|
| Market Cap Growth | 38.90% | 38.90% | -7.42% | 177.28% | 101.66% | -10.41% | Upgrade
|
| Enterprise Value | 2,153 | 2,050 | 1,675 | 1,684 | 528 | 219 | Upgrade
|
| Last Close Price | 21.96 | 20.87 | 16.81 | 18.60 | 6.77 | 3.34 | Upgrade
|
| PE Ratio | 16.76 | 15.19 | 25.10 | 23.30 | 17.68 | 4.62 | Upgrade
|
| Forward PE | 15.54 | 15.38 | 14.13 | 14.98 | 13.97 | 8.97 | Upgrade
|
| PS Ratio | 5.29 | 5.06 | 4.50 | 9.04 | 4.96 | 2.91 | Upgrade
|
| PB Ratio | 3.65 | 3.42 | 4.62 | 6.44 | 3.38 | 2.04 | Upgrade
|
| P/TBV Ratio | 4.36 | 4.36 | 9.25 | 7.22 | 3.38 | 2.04 | Upgrade
|
| P/FCF Ratio | 11.15 | 10.40 | - | 18.26 | 11.76 | 7.69 | Upgrade
|
| P/OCF Ratio | 11.12 | 10.38 | 12.48 | 16.68 | 11.56 | 7.69 | Upgrade
|
| EV/Sales Ratio | 4.38 | 4.17 | 4.21 | 7.86 | 3.75 | 1.84 | Upgrade
|
| EV/EBITDA Ratio | 9.24 | 8.80 | 13.99 | 16.33 | 10.03 | 5.30 | Upgrade
|
| EV/EBIT Ratio | 11.03 | 10.51 | 19.29 | 16.53 | 10.07 | 5.31 | Upgrade
|
| EV/FCF Ratio | 9.00 | 8.57 | - | 15.88 | 8.89 | 4.87 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.03 | 0.04 | 0.08 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | - | 0.04 | 0.07 | 0.00 | Upgrade
|
| Asset Turnover | 0.74 | 0.74 | 0.94 | 0.70 | 0.65 | 0.78 | Upgrade
|
| Inventory Turnover | 4.01 | 4.01 | 4.76 | 4.92 | 6.20 | 10.15 | Upgrade
|
| Quick Ratio | 4.83 | 4.83 | 2.51 | 5.37 | 7.32 | 6.45 | Upgrade
|
| Current Ratio | 5.17 | 5.17 | 2.88 | 5.57 | 7.76 | 7.00 | Upgrade
|
| Return on Equity (ROE) | 29.38% | 29.38% | 20.75% | 32.76% | 20.98% | 58.30% | Upgrade
|
| Return on Assets (ROA) | 18.46% | 18.46% | 12.83% | 20.75% | 15.22% | 16.94% | Upgrade
|
| Return on Capital (ROIC) | 21.73% | 21.73% | 15.60% | 24.70% | 17.20% | 20.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 26.70% | 26.70% | 22.03% | 32.02% | 24.86% | 24.35% | Upgrade
|
| Earnings Yield | 6.14% | 6.58% | 3.98% | 4.29% | 5.66% | 21.66% | Upgrade
|
| FCF Yield | 8.97% | 9.61% | -3.06% | 5.48% | 8.50% | 13.01% | Upgrade
|
| Buyback Yield / Dilution | -9.84% | -9.84% | -2.13% | -3.32% | -1.46% | -0.21% | Upgrade
|
| Total Shareholder Return | -9.84% | -9.84% | -2.13% | -3.32% | -1.46% | -0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.